S
Spero Therapeutics (SPRO)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Spero Therapeutics (SPRO)
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing novel treatments for MDR bacterial infections. Its lead product candidate, tebipenem HBr (tebipenem pivoxil ... Read more
- USD0.58
- USD0.64
- USD0.57
- USD1.69
- 5.10%
- 48M
- 81.46k
- 110.27k
- 36M
- 0.51
- -63.30%
Stock News
2 hours ago
Stock-market bulls face inflation test this week, but trade talks may set the tone
MarketWatch
6 hours ago
Adtalem Global Education: A Picks-And-Shovels Play On The U.S. Healthcare Labor Crisis
SeekingAlpha
6 hours ago
The Real Brokerage Inc. 2025 Q1 - Results - Earnings Call Presentation
SeekingAlpha
6 hours ago
Invesco Rising Dividends Fund Q1 2025 Commentary
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
